CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Systemic therapy augmented by radiotherapy (STAR) effect for brain metastases in a BRAF-mutated melanoma patient with prolonged survival: a case report

Agostino Cristaudo, Antonio Malorgio, Serena Medoro, Antonio Stefanelli

Radiation Oncology Journal. 2021;39(1):78-81. Published online 2021 March 3 DOI: https://doi.org/10.3857/roj.2020.00724

Systemic therapy augmented by radiotherapy (STAR) effect for brain metastases in a BRAF-mutated melanoma patient with prolonged survival: a case report

Agostino Cristaudo, Antonio Malorgio, Serena Medoro, Antonio Stefanelli

Radiation Oncology Journal. 2021;39(1):78-81

Link1

Link2 Link3

Targeted Therapy After Brain Radiotherapy for BRAF-Mutated Melanoma With Extensive Ependymal Disease With Prolonged Survival: Case Report and Review of the Literature

Ibrahim Abu-Gheida, Samuel Chao, Erin Murphy, John Suh, Glen H. Stevens, Alireza M. Mohammadi, Michael McNamara, Jennifer S. Yu

Frontiers in Oncology. 2019;9:

Link1

Prolonged survival of a patient with metastatic leptomeningeal melanoma treated with BRAF inhibition-based therapy: a case report

Dae Won Kim, Edelyn Barcena, Urvi N Mehta, Michelle L Rohlfs, Ashok J Kumar, Marta Penas-Prado, Kevin B Kim

BMC Cancer. 2015;15(1):

Link1 Link2

Link3 Link4

Integrating Systemic Therapy into the Management of Brain Metastases

John B. Fiveash, Anatoly Nikolaev, Robert M. Conry

Radiotherapy in Managing Brain Metastases. 2020;95-108

Link1

BRAF inhibitors and radiotherapy for melanoma brain metastases: potential advantages and disadvantages of combination therapy

Mudit Chowdhary, Kirtesh R Patel, Hasan H Danish, David H Lawson, Mohammad K Khan

OncoTargets and Therapy. 2016;Volume 9:7149-7159

Link1 Link2

Systemic Therapy for Brain Metastases: Melanoma

Sarah Weiss, Harriet Kluger

Central Nervous System Metastases. 2020;235-244

Link1

Co‐existence of BRAF V600E ‐mutated malignant melanoma and BRAF V600E‐mutated Langerhans cell histiocytosis: A case report

Keisuke Goto, Shusuke Yoshikawa, Yoshio Kiyohara, Yoji Kukita, Keiko Miura, Takuma Oishi

Journal of Cutaneous Pathology. 2021;

Link1 Link2 Link3

Neurological benefit of BRAF-inhibition and MEK-inhibition in patients with brain metastases from BRAF-mutated melanoma

M. Geukes Foppen, W. Boogerd, C. Blank, J.B.A.G. Haanen, J.V. van Thienen, D. Brandsma

Annals of Oncology. 2016;27:vi391

Link1 Link2 Link3

Melanoma Brain Metastases: Unique Biology and Implications for Systemic Therapy

Kim Margolin, Michael Davies, Harriet Kluger, Hussein Tawbi

Cutaneous Melanoma. 2020;1421-1454

Link1

Niraparib as Maintenance Therapy in Germline ATM-mutated and Somatic BRCA2-mutated Ovarian Cancer with Brain Metastases: A Case Report and Literature Review

Mengyu Tao, Jiejun Cheng, Xia Wu

OncoTargets and Therapy. 2020;Volume 13:12979-12986

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Radiat Oncol J has participated in CrossRef Text and Data Mining service since October 29, 2014.